2m 2m 2m 2m 2m 2m 2m
CERVOMED (CRVO)
NASDAQ
$2.61+$0.03 (+1.16%)
Price as of Aug 03, 2026 11:34 AM EDT- $23.9MMarket Cap
- -70.78%1-Year Change
- BiotechnologyIndustry
CERVOMED (CRVO)
$2.61+$0.03 (+1.16%)
CRVO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.58 | ||
Change | +$0.06 (+2.38%) | ||
Open | $2.51 | ||
High | $2.60 | ||
Low | $2.46 | ||
Previous Close | $2.52 | ||
Volume | 238,564 | ||
30-Day Average Volume | 546,803 | ||
1-Week Change | -3.01% | ||
1-Month Change | -16.77% | ||
1-Year Change | -70.78% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.3M | ||
Total Assets | $15.1M | ||
Market Cap | $23.9M | ||
Enterprise Value | $15.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$8.0M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$8.0M | ||
EBITDA | -$8.0M | ||
Net Working Capital | $12.8M | ||
EPS | -$0.86 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -3 | ||
PEG | -2 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 04/19/2022 | ||
Earnings & Revenue